Jun
8
2022
On demand
Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
In this webinar, you will learn about cutting-edge organ chip technology already in use by several of the top pharmaceutical companies for drug development and immuno-oncology applications. Most cells in our body are no farther from a blood vessel than the width of a hair. Blood vessels help pattern tissues and provide them with their nutrients, and since almost all therapeutics — whether small molecules, antibodies, or leukocytes — reach our tissues via blood vessels, no model of tissue-drug interaction is realistic without this supporting vascular network. You will learn what readouts are available in vitro for developing drug, cell and gene-based therapies, including:
- Continual imaging of tumor growth and response to drugs
- Imaging of leukocyte vascular adhesion & extravasation
- Assessment of tumor occupancy and killing by leukocytes, including CAR-Ts
- Assessment of monoclonal antibody & bispecific delivery and efficacy
- Assessment of target gene expression by in situ staining or qPCR
- Collection of venous outflow for assessment of biomarkers
Attend this webinar to learn:
- How responses in Vascularized Micro-Tumor chips compare to responses seen in patient tumors
- What types of drug, cell-based and gene therapy studies can be conducted using Vascularized-Micro Tumor chips
- How Vascularized Micro-Tumor chips compare to other models, such as 2D cell culture or spheroid models
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Emily Neil, Ariadna Pascual
27 June
in 63
Days
Precision in production: optimizing monitoring and quality control for high-value plasmids
Oleksandr Karpenko
6 June
in 42
Days
Advancing cell therapy: innovations in polymer-based encapsulation and delivery
B Yevgeniy, O Veiseh, M Delic-Schlumbohm et al.
5 June
in 41
Days
Pure and simple: understanding LNP analytics for better mRNA-based drugs
Adam Crowe
29 May
in 34
Days
Empowering patient care: in-process and quality control solutions for cellular therapies
Christin Tischner, Simon Lennartz
23 May
in 28
Days